Equities

Nu-Med Plus Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
NUMD:QBB

Nu-Med Plus Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)0.0153
  • Today's Change0.00 / 0.00%
  • Shares traded200.00
  • 1 Year change+13.33%
  • Beta-3.2718
Data delayed at least 15 minutes, as of Feb 05 2026 16:42 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Nu-Med Plus, Inc. is a medical device company principally engaged in the design, innovation, development, enhancement, and commercialization of beginning, early, and later-stage quality medical devices. It focuses on the creation of a nitric oxide (NO) generating formulation, a hospital bedside NO delivery system, a clinical unit for use in medical clinics and rehabilitation centers and a mobile rechargeable device to deliver nitric oxide gas to offer solutions to hospitals, health systems and the medical community throughout the world. Hospital NO Unit delivers a continuous intra-breath concentration of therapeutic NO to patients who are on a ventilator in a hospital setting. The Clinical Delivery System is a simplified version of the hospital unit. Portable Delivery System delivers NO to the patient at prescribed intervals for 24 hours per day at controlled doses by means of a nasal cannula or a face mask. Reagent Delivery offers a range of concentrations and flow rates of NO.

  • Revenue in USD (TTM)0.00
  • Net income in USD-54.13k
  • Incorporated2011
  • Employees2.00
  • Location
    Nu-Med Plus Inc455 East 500 South, Suite #203SALT LAKE CITY 84111United StatesUSA
  • Phone+1 (801) 746-3570
  • Websitehttps://yourspaceamerica.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Nano Mobile Healthcare Inc0.00-5.46m654.75k3.00---------0.2255-0.22550.00-0.01290.00----0.00-10,475.82-----------------0.3173----------------
Nouveau Life Pharmaceuticals Inc0.00-504.00k666.10k0.00--0.0113-----0.0168-0.01680.000.00880.00-------39.38---110.89-------------4.200.5507-------38.91------
Electromedical Technologies Inc922.02k-1.68m746.46k6.00------0.8096-0.0035-0.00350.001-0.00551.302.95112.10153,670.00-236.02-340.23----75.0875.94-182.03-406.260.0645-1.02----17.3014.8426.05------
Venus Concept Inc58.88m-54.61m747.37k292.00--0.2796--0.0127-46.93-46.9348.241.440.87941.213.13201,630.10-81.66-34.89-199.53-47.8164.3667.86-92.86-54.810.5934-6.680.9056---15.09-10.10-26.16---35.75--
Medical Care Technologies Inc.0.00-1.07m821.00k0.00---------553,570.10-553,570.100.00-389.230.00-------154.94-----------------1.46---------40.06------
CYIOS Corp1.49m-59.20k830.50k15.00--0.3151--0.5562-0.0016-0.00160.04110.00863.51--9.5199,542.66-13.93-21.69-17.32-60.1543.6742.72-3.96-4.54----0.0867--4.142.47130.18------
Leafbuyer Technologies Inc5.84m205.18k1.00m12.004.88----0.17150.0020.0020.0583-0.01426.35--71.02486,275.0022.33-44.28----44.0437.833.52-21.61--3.07----15.5420.68136.74-27.51----
Sigyn Therapeutics Inc0.00-3.22m1.20m4.00---------2.01-2.010.00-3.690.00----0.00-1,144.23-590.29---------------3.44--------19.43------
Zynex Inc108.20m-73.96m1.22m1.00k------0.0112-2.43-2.433.49-1.341.262.207.64108,202.00-86.3110.48-203.5512.4271.9079.57-68.357.510.3174-12.223.19--4.3633.44-69.24-20.6129.29--
Nu-Med Plus Inc0.00-54.13k1.28m2.00---------0.0006-0.00060.00-0.00310.00----0.00-910.51-451.95---------------8.61--------45.55------
Escalon Medical Corp11.94m-200.38k1.44m39.00--1.40--0.1209-0.0436-0.04361.110.22592.573.677.31306,156.90-2.201.53-4.993.4845.3843.87-0.85520.70260.979-1.960.1335--0.53955.09115.88---42.12--
Data as of Feb 05 2026. Currency figures normalised to Nu-Med Plus Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.